Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Stockholders Equity of $305.79 million for fiscal year 2025.
CAPRICOR THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $305.79M | +110.2% |
| 2024 | $145.46M | +543.6% |
| 2023 | $22.60M | +91.8% |
| 2022 | $11.79M | -62.4% |
| 2021 | $31.37M | +11.2% |
| 2020 | $28.20M | +312.3% |
| 2019 | $6.84M | +48.2% |
| 2018 | $4.62M | -58.9% |
| 2017 | $11.23M | +380.5% |
| 2016 | -$4.00M | -288.0% |
| 2015 | -$1.03M | +83.5% |
| 2014 | -$6.25M | -1068.2% |
| 2013 | -$534.9K | -110.9% |
| 2012 | $4.89M | +195.7% |
| 2011 | $1.66M | -7.5% |
| 2010 | $1.79M | +96.2% |
| 2009 | $911.8K | +261.0% |
| 2008 | $252.6K | -70.7% |
| 2007 | $863.2K | -53.0% |
| 2006 | $1.84M | — |
| 2005 | $0.00 | — |
| 2005 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $83.87M | +22.9% | -20.1% |
| June 30, 2025 | $104.98M | +812.7% | -17.8% |
| March 31, 2025 | $127.65M | +592.4% | -12.2% |
| December 31, 2024 | $145.46M | +543.6% | +113.1% |
| September 30, 2024 | $68.26M | +3918.7% | +493.5% |
| June 30, 2024 | $11.50M | +321.2% | -37.6% |
| March 31, 2024 | $18.43M | +197.0% | -18.4% |
| December 31, 2023 | $22.60M | +91.8% | +1364.3% |
- CAPRICOR THERAPEUTICS, INC. showed an increase of +110.2% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from CAPRICOR THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: